Building on the success and interest in our 1st European Biotransformation Workshop held in January 2021, this is our second meeting. Feedback received on our first workshop suggested a number of further important topics on biotransformation, and to cover it all the second workshop will be a 2-day event. The first day will cover new modality drugs, e.g., oligonucleotides, peptides, antibody drug conjugates, etc. The second day will be devoted to small molecule biotransformation.

Speakers are being invited and we are confident the program will be equally important and up-to-date as previously. The purpose of this workshop is to provide a platform for biotransformation scientists to discuss topics of interest to them and the biotransformation community at large. This workshop will be delivered online, using the DMDG Secretariat's one-stop webinar solution to replicate the face-2-face workshop as much as possible. The meeting format will comprise short presentations, panel discussions and breakout sessions to discuss messages of presentations in smaller groups.